MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified.
Recent studies provide convincing evidence that a combined immunohistochemical or fluorescence in situ hybridization (FISH) score of MYC, BCL2, BCL6 proteins and MYC translocations predicted outcome in diffuse large B-cell lymphoma (DLBCL) patients treated with rituximab, cyclophosphamide, doxorubic...
Main Authors: | Li-Xu Yan, Yan-Hui Liu, Dong-Lan Luo, Fen Zhang, Yu Cheng, Xin-Lan Luo, Jie Xu, Jie Cheng, Heng-Guo Zhuang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4121314?pdf=render |
Similar Items
-
Correction: MYC Expression in Concert With BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
by: Li-Xu Yan, et al.
Published: (2018-01-01) -
Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
by: The Staff
Published: (2014-01-01) -
Correction: MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified.
Published: (2014-01-01) -
BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified
by: Mario L. Marques-Piubelli, et al.
Published: (2021-09-01) -
BCL6 mRNA Expression Level in Invasive Duct Carcinoma not otherwise Specified
by: Eman Badr, et al.
Published: (2016-12-01)